Modulation of gel temperature of poloxamer-containing formulations
作者： Fabrice Piu , Qiang Ye , Luis A. Dellamary
DOI:
关键词:
摘要: Disclosed herein are methods for modulation of gel temperature poloxamer-containing formulations. Also described sustained release pharmaceutical formulations that upon contact with the body and administered by direct application these compositions onto or via perfusion into targeted structure(s).
google.it 参考文章(43)
Paul Glidden, Business methods for modulating angiogenesis ,(2004)
Huawei Li, Albert Edge, Stefan Heller, None, Use of stem cells to generate inner ear cells ,(2005)
James A. Wilkie, Jean-Marie Vogel, Peter N. Madras, Perfusive organ hemostasis ,(2007)
Raj Kewalramani, Jack Michael Shaw, John Pruitt, David Slifer, Stephen B. Ruddy, Sterilized nanoparticulate glucocorticosteroid formulations ,(2007)
Aurelio Romeo, Bruno Silvestrini, Gunter Kirschner, Pharmaceutical preparations comprised of salts of hyaluronic acid with local anaesthetics ,(1997)
Chung Shih, Gaylen M. Zentner, Agent delivering system comprised of microparticle and biodegradable gel with an improved releasing profile and methods of use thereof ,(2000)
William G. Hubbard, Injectable hydrogels and methods of making and using same ,(2006)
Karsten Gröger, Reinhard Schmitz, Sigrid Keipert, Christian Schnittker, Carlo Alberto Maggi, Stefano Manzini, Stabilized brivudine topical formulations ,(2002)
Santosh Kumar Chandrasekaran, Lyle M. Bowman, Erwin C. Si, Topical otic compositions and methods of topical treatment or prevention of otic infections ,(2005)
Karl H. Willert, Roeland Nusse, Compositions of active Wnt protein ,(2015)